We therefore aimed to characterize RANKL, RANK and OPG expression in the synovial membrane of early-untreated RA in relation to local inflammation and disease activity and to investigate how expression of these molecules might change following MTX treatment. The gene discussed is TNFRSF11B; the disease is rheumatoid arthritis.